Literature DB >> 22265212

Posterior cortical atrophy.

Sebastian J Crutch1, Manja Lehmann, Jonathan M Schott, Gil D Rabinovici, Martin N Rossor, Nick C Fox.   

Abstract

Posterior cortical atrophy (PCA) is a neurodegenerative syndrome that is characterised by progressive decline in visuospatial, visuoperceptual, literacy, and praxic skills. The progressive neurodegeneration affecting parietal, occipital, and occipitotemporal cortices that underlies PCA is attributable to Alzheimer's disease in most patients. However, alternative underlying causes, including dementia with Lewy bodies, corticobasal degeneration, and prion disease, have also been identified, and not all patients with PCA have atrophy on clinical imaging. This heterogeneity has led to inconsistencies in diagnosis and terminology and difficulties in comparing studies from different centres, and has restricted the generalisability of findings from clinical trials and investigations of factors that drive phenotypic variability. Important challenges remain, including the identification of factors associated not only with the selective vulnerability of posterior cortical regions but also with the young age of onset of PCA. Greater awareness of the syndrome and agreement over the correspondence between syndrome-level and disease-level classifications are needed to improve diagnostic accuracy, clinical management, and the design of research studies.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22265212      PMCID: PMC3740271          DOI: 10.1016/S1474-4422(11)70289-7

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  73 in total

1.  The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Authors:  Guy M McKhann; David S Knopman; Howard Chertkow; Bradley T Hyman; Clifford R Jack; Claudia H Kawas; William E Klunk; Walter J Koroshetz; Jennifer J Manly; Richard Mayeux; Richard C Mohs; John C Morris; Martin N Rossor; Philip Scheltens; Maria C Carrillo; Bill Thies; Sandra Weintraub; Creighton H Phelps
Journal:  Alzheimers Dement       Date:  2011-04-21       Impact factor: 21.566

2.  Posterior cortical atrophy: a rare visual variant of Alzheimer's disease.

Authors:  V Abdul Gafoor; James Jose; K Saifudheen; Mohamed Musthafa
Journal:  Neurol India       Date:  2011 Mar-Apr       Impact factor: 2.117

3.  Similar amyloid-β burden in posterior cortical atrophy and Alzheimer's disease.

Authors:  Leonardo Cruz de Souza; Fabian Corlier; Marie-Odile Habert; Olga Uspenskaya; Renaud Maroy; Foudil Lamari; Marie Chupin; Stéphane Lehéricy; Olivier Colliot; Valérie Hahn-Barma; Dalila Samri; Bruno Dubois; Michel Bottlaender; Marie Sarazin
Journal:  Brain       Date:  2011-07       Impact factor: 13.501

4.  Progressive biparietal atrophy: an atypical presentation of Alzheimer's disease.

Authors:  S J Ross; N Graham; L Stuart-Green; M Prins; J Xuereb; K Patterson; J R Hodges
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-10       Impact factor: 10.154

5.  Visuo-spatial imagery impairment in posterior cortical atrophy: a cognitive and SPECT study.

Authors:  Simona Gardini; Letizia Concari; Salvatrice Pagliara; Caterina Ghetti; Annalena Venneri; Paolo Caffarra
Journal:  Behav Neurol       Date:  2011       Impact factor: 3.342

6.  Visual hallucinations in posterior cortical atrophy.

Authors:  Keith A Josephs; Jennifer L Whitwell; Bradley F Boeve; David S Knopman; David F Tang-Wai; Daniel A Drubach; Clifford R Jack; Ronald C Petersen
Journal:  Arch Neurol       Date:  2006-10

7.  Cognitive phenotypes in Alzheimer's disease and genetic risk.

Authors:  Julie S Snowden; Cheryl L Stopford; Camille L Julien; Jennifer C Thompson; Yvonne Davidson; Linda Gibbons; Antonia Pritchard; Corinne L Lendon; Anna M Richardson; Anoop Varma; David Neary; David Mann
Journal:  Cortex       Date:  2007-10       Impact factor: 4.027

8.  What are we seeing? Is posterior cortical atrophy just Alzheimer disease?

Authors:  David Tang-Wai; Mark Mapstone
Journal:  Neurology       Date:  2006-02-14       Impact factor: 9.910

9.  Evaluating atypical dementia syndromes using positron emission tomography with carbon 11 labeled Pittsburgh Compound B.

Authors:  Steven Y Ng; Victor L Villemagne; Colin L Masters; Christopher C Rowe
Journal:  Arch Neurol       Date:  2007-08

10.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.

Authors:  L A Farrer; L A Cupples; J L Haines; B Hyman; W A Kukull; R Mayeux; R H Myers; M A Pericak-Vance; N Risch; C M van Duijn
Journal:  JAMA       Date:  1997 Oct 22-29       Impact factor: 56.272

View more
  174 in total

1.  Treatment of a patient with posterior cortical atrophy (PCA) with chiropractic manipulation and Dynamic Neuromuscular Stabilization (DNS): A case report.

Authors:  Vinicius T Francio; Ron Boesch; Michael Tunning
Journal:  J Can Chiropr Assoc       Date:  2015-03

2.  Cerebrospinal fluid biomarkers and cerebral atrophy in distinct clinical variants of probable Alzheimer's disease.

Authors:  Rik Ossenkoppele; Niklas Mattsson; Charlotte E Teunissen; Frederik Barkhof; Yolande Pijnenburg; Philip Scheltens; Wiesje M van der Flier; Gil D Rabinovici
Journal:  Neurobiol Aging       Date:  2015-04-25       Impact factor: 4.673

3.  [Posterior cortical atrophy-a heterogeneous syndrome : A case series].

Authors:  Julian Conrad; Olympia Kremmyda; Tobias Högen; Matthias Brendel; Axel Rominger; Johannes Levin; Adrian Danek
Journal:  Nervenarzt       Date:  2019-10       Impact factor: 1.214

4.  Homonymous Hemianopsia Due to Posterior Cortical Atrophy.

Authors:  Francesco Pellegrini; Andrew G Lee; Pietro Zucchetta
Journal:  Neuroophthalmology       Date:  2017-02-15

5.  Prediction of Alzheimer's disease in subjects with mild cognitive impairment from the ADNI cohort using patterns of cortical thinning.

Authors:  Simon F Eskildsen; Pierrick Coupé; Daniel García-Lorenzo; Vladimir Fonov; Jens C Pruessner; D Louis Collins
Journal:  Neuroimage       Date:  2012-10-02       Impact factor: 6.556

Review 6.  The path to biomarker-based diagnostic criteria for the spectrum of neurodegenerative diseases.

Authors:  Filippo Baldacci; Sonia Mazzucchi; Alessandra Della Vecchia; Linda Giampietri; Nicola Giannini; Maya Koronyo-Hamaoui; Roberto Ceravolo; Gabriele Siciliano; Ubaldo Bonuccelli; Fanny M Elahi; Andrea Vergallo; Simone Lista; Filippo Sean Giorgi; Harald Hampel
Journal:  Expert Rev Mol Diagn       Date:  2020-02-27       Impact factor: 5.225

7.  Alzheimer's disease first symptoms are age dependent: Evidence from the NACC dataset.

Authors:  Josephine Barnes; Bradford C Dickerson; Chris Frost; Lize C Jiskoot; David Wolk; Wiesje M van der Flier
Journal:  Alzheimers Dement       Date:  2015-04-24       Impact factor: 21.566

8.  Non-pharmacological intervention for posterior cortical atrophy.

Authors:  Agnès Weill-Chounlamountry; Jorge Alves; Pascale Pradat-Diehl
Journal:  World J Clin Cases       Date:  2016-08-16       Impact factor: 1.337

Review 9.  Posterior Cortical Atrophy.

Authors:  Jonathan M Schott; Sebastian J Crutch
Journal:  Continuum (Minneap Minn)       Date:  2019-02

Review 10.  Dementia and neuroimaging.

Authors:  Federica Agosta; Francesca Caso; Massimo Filippi
Journal:  J Neurol       Date:  2012-12-15       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.